Structural basis of the effect of activating mutations on the EGF receptor

Ioannis Galdadas1,2, Luca Carlino3, Richard A Ward3

  • 1Department of Chemistry, University College London, London, United Kingdom.

Elife
|July 28, 2021
PubMed

Insights

Mutations in the epidermal growth factor receptor (EGFR) kinase domain drive lung cancer. This study reveals how specific EGFR mutations alter receptor conformation, leading to uncontrolled cell growth and aberrant signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biophysics

Background:

  • Mutations in the epidermal growth factor receptor (EGFR) kinase domain are key drivers in non-small cell lung cancer.
  • EGFR activation in normal cells relies on growth factor-induced dimerization, but mutations can cause constitutive activation.

Purpose of the Study:

  • To investigate the conformational landscapes of wild-type and mutated EGFR monomers and homodimers.
  • To elucidate the molecular mechanisms by which EGFR mutations lead to aberrant signaling and cancer.

Main Methods:

  • Utilized molecular dynamics simulations.
  • Employed enhanced sampling techniques to analyze conformational dynamics.
  • Compared wild-type EGFR with specific mutations (ΔELREA, L858R) and exon 20 insertions (D770-N771insNPG, A763-Y764insFQEA).

Main Results:

  • Identified distinct conformational energy landscapes for wild-type and mutated EGFR.
  • Observed mutation-specific effects on hinge motion, dimeric interface stability, and local unfolding.
  • These conformational changes correlate with growth factor-independent kinase activation.

Conclusions:

  • EGFR mutations employ diverse mechanisms to achieve aberrant signaling.
  • Conformational changes, including hinge motion regulation and interface stabilization, contribute to oncogenesis.
  • Understanding these mechanisms provides insights into targeted cancer therapies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
81.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.4K